Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy

Christine E Jones, Flor M Munoz, Sonali Kochhar, Stefania Vergnano, Clare L Cutland, Mark Steinhoff, Steven Black, Ulrich Heininger, Jan Bonhoeffer, Paul T Heath, Christine E Jones, Flor M Munoz, Sonali Kochhar, Stefania Vergnano, Clare L Cutland, Mark Steinhoff, Steven Black, Ulrich Heininger, Jan Bonhoeffer, Paul T Heath

Abstract

Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection and reporting of critical data to allow comparisons and data pooling becomes more important. The Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project aims to improve data collection and create a shared understanding of maternal, fetal and neonatal outcomes in order to progress the global agenda for vaccination in pregnancy. The guidance in this document has been developed to harmonize the data collected in case report forms used for safety monitoring in clinical trials of vaccination in pregnant women. Data to be collected is prioritized to allow applicability in diverse research settings, including low and middle-income countries. Standardized data will enable the research community to have a common base upon which to conduct meta-analyses, strengthening the applicability of outcomes to different settings.

Keywords: Adverse event; Case report form; Clinical trials; Guidance; Immunization; Pregnancy; Safety; Vaccines.

Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

References

    1. Madhi S.A., Cutland C.L., Kuwanda L., Weinberg A., Hugo A., Jones S. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918–931.
    1. Blencowe H., Lawn J., Vandelaer J., Roper M., Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010;39:i102–i109.
    1. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384:1521–1528.
    1. Dabrera G., Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and wales, 2012–2013. Clin Infect Dis. 2015;60:333–337.
    1. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555–1564.
    1. Heath P.T. An update on vaccination against group B streptococcus. Expert Rev Vaccines. 2011;10:685–694.
    1. Munoz F.M. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis. 2015;28:221–224.
    1. Fulton T.R., Narayanan D., Bonhoeffer J., Ortiz J.R., Lambach P., Omer S.B. A systematic review of adverse events following immunization during pregnancy and the newborn period. Vaccine. 2015;33:6453–6465.
    1. The First International Neonatal Vaccination Workshop, 2–4 March 2004. Available from: <> [accessed May 9, 2016].
    1. Fondation Merieux. Maternal immunization: challenges and opportunities, 24–26 September 2012, Les Pensières, Annecy, France. Available from: <> [accessed May 9, 2016].
    1. Brighton Collaboration Foundation. Our workflow of developing case definitions and complementary guidelines. Available from: <> [accessed May 9, 2016].
    1. International Alliance for Biological Standardization. Harmonized safety monitoring of immunization pregnancy international consensus conference, March 29–30, 2016, Bethesda, Maryland, USA: National Institutes of Health. Available from: <?> [accessed May 9, 2016].
    1. Bonhoeffer J., Imoukhuede E.B., Aldrovandi G., Bachtiar N.S., Chan E.-S., Chang S. Template protocol for clinical trials investigating vaccines—focus on safety elements. Vaccine. 2013;31:5602–5620.
    1. Harrison M.S., Eckert L.O., Cutland C., Gravett M., Harper D.M., McClure E.M. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016;34:6093–6101.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir